To date, roles for only NTN1 and NTN4 have been described in breast cancer, ovarian cancer, prostate cancer, and pancreatic cancer among endocrine system-related tumors and sex hormone-targeting tumors. This evidence concerns the gene NTN4 and familial pancreatic carcinoma.